Urogen Pharma's total assets for Q2 2025 were $208.72M, a decrease of -15.71% from the previous quarter. URGN total liabilities were $302.09M for the fiscal quarter, a 2.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.